{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T07:53:07Z","timestamp":1770450787007,"version":"3.49.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.medcli.2017.06.066","type":"journal-article","created":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T05:01:07Z","timestamp":1504242067000},"page":"26-32","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Hechos y controversias en la enfermedad mixta del tejido conectivo"],"prefix":"10.1016","volume":"150","author":[{"given":"Julia","family":"Mart\u00ednez-Barrio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lara","family":"Valor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. Javier","family":"L\u00f3pez-Longo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2017.06.066_bib0305","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/0002-9343(72)90064-2","article-title":"Mixed connective tissue disease--An apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA)","volume":"52","author":"Sharp","year":"1972","journal-title":"Am J Med."},{"key":"10.1016\/j.medcli.2017.06.066_bib0310","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1056\/NEJM197611182952101","article-title":"Association of antibodies to ribonucleoprotein and Sm antigens with mixed connective-tissue disease, systematic lupus erythematosus and other rheumatic diseases","volume":"295","author":"Sharp","year":"1976","journal-title":"N Engl J Med."},{"key":"10.1016\/j.medcli.2017.06.066_bib0315","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1136\/ard.37.5.397","article-title":"The arthritis of mixed connective tissue disease","volume":"37","author":"Bennett","year":"1978","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.medcli.2017.06.066_bib0320","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0049-0172(80)90013-X","article-title":"Mixed connective tissue disease: A clinicopathologic study of 20 cases","volume":"10","author":"Bennett","year":"1980","journal-title":"Semin Arthritis Rheum."},{"key":"10.1016\/j.medcli.2017.06.066_bib0325","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1002\/acr.22872","article-title":"Epidemiology of mixed connective tissue disease 1985-2014: A population based study","volume":"68","author":"Ungprasert","year":"2016","journal-title":"Arthritis Care Res (Hoboken)."},{"key":"10.1016\/j.medcli.2017.06.066_bib0330","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1136\/ard.2010.143792","article-title":"The prevalence and incidence of mixed connective tissue disease: A national multicentre survey of Norwegian patients","volume":"70","author":"Gunnarsson","year":"2011","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.medcli.2017.06.066_bib0335","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/art.1780330509","article-title":"Human autoantibodies against the 70-kd polypeptide of U1 small nuclear RNP are associated with HLA-DR4 among connective tissue disease patients","volume":"33","author":"Hoffman","year":"1990","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.medcli.2017.06.066_bib0340","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/tan.12698","article-title":"Association of HLA-DRB1 alleles with susceptibility to mixed connective tissue disease in Polish patients","volume":"87","author":"Paradowska-Gorycka","year":"2016","journal-title":"HLA."},{"key":"10.1016\/j.medcli.2017.06.066_bib0345","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1093\/rheumatology\/keu310","article-title":"The HLA profiles of mixed connective tissue disease differ distinctly from the profiles of clinically related connective tissue diseases","volume":"54","author":"Fl\u00e5m","year":"2015","journal-title":"Rheumatology (Oxford)."},{"key":"10.1016\/j.medcli.2017.06.066_bib0350","doi-asserted-by":"crossref","first-page":"e1000696","DOI":"10.1371\/journal.pgen.1000696","article-title":"High-density SNP screening of the major histocompatibility complex in systemic lupus erythematosus demonstrates strong evidence for independent susceptibility regions","volume":"5","author":"Barcellos","year":"2009","journal-title":"PLoS Genet."},{"key":"10.1016\/j.medcli.2017.06.066_bib0355","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.rdc.2007.10.001","article-title":"Genetics and genomic studies in scleroderma (systemic sclerosis)","volume":"34","author":"Agarwal","year":"2008","journal-title":"Rheum Dis Clin North Am."},{"key":"10.1016\/j.medcli.2017.06.066_bib0360","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/01.md.0000189818.63141.8c","article-title":"Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: Distinct HLA-A, -B, -Cw, -DRB1 and -DQA1 allelic profiles and motifs define clinicopathologic groups in caucasians","volume":"84","author":"O\u2019Hanlon","year":"2005","journal-title":"Medicine (Baltimore)."},{"key":"10.1016\/j.medcli.2017.06.066_bib0365","first-page":"663","article-title":"Nailfold capillaroscopy and classification criteria for systemic sclerosis","volume":"25","author":"Cutolo","year":"2007","journal-title":"Clin Exp Rheumatol."},{"key":"10.1016\/j.medcli.2017.06.066_bib0370","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.3899\/jrheum.121272","article-title":"Clinical course, prognosis, and causes of death in mixed connective tissue disease","volume":"40","author":"Hajas","year":"2013","journal-title":"J Rheumatol."},{"key":"10.1016\/j.medcli.2017.06.066_bib0375","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1136\/annrheumdis-2011-201253","article-title":"Prevalence and severity of interstitial lung disease in mixed connective tissue disease: A nationwide, cross-sectional study","volume":"71","author":"Gunnarsson","year":"2012","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.medcli.2017.06.066_bib0380","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.rdc.2015.01.001","article-title":"Pulmonary manifestations of Sj\u00f6gren syndrome, systemic lupus erythematosus, and mixed connective tissue disease","volume":"41","author":"Mira-Avendano","year":"2015","journal-title":"Rheum Dis Clin North Am."},{"key":"10.1016\/j.medcli.2017.06.066_bib0385","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.rdc.2013.10.001","article-title":"Pulmonary arterial hypertension related to connective tissue disease. A review","volume":"40","author":"Ahmed","year":"2014","journal-title":"Rheum Dis Clin North Am."},{"key":"10.1016\/j.medcli.2017.06.066_bib0390","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1177\/0961203312456751","article-title":"Distinct phenotypes in mixed connective tissue disease: Subgroups and survival","volume":"21","author":"Szodoray","year":"2012","journal-title":"Lupus."},{"key":"10.1016\/j.medcli.2017.06.066_bib0395","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.rdc.2005.04.010","article-title":"Pulmonary vascular manifestations of mixed connective tissue disease","volume":"31","author":"Bull","year":"2005","journal-title":"Rheum Dis Clin North Am."},{"key":"10.1016\/j.medcli.2017.06.066_bib0400","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.rmed.2008.12.018","article-title":"Esophageal involvement and interstitial lung disease in mixed connective tissue disease","volume":"103","author":"Fagundes","year":"2009","journal-title":"Respir Med."},{"key":"10.1016\/j.medcli.2017.06.066_bib0405","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.berh.2012.01.009","article-title":"Mixed connective tissue disease: An overview of clinical manifestations, diagnosis and treatment","volume":"26","author":"Ortega-Hernandez","year":"2012","journal-title":"Best Pract Res Clin Rheumatol."},{"key":"10.1016\/j.medcli.2017.06.066_bib0410","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.3899\/jrheum.081314","article-title":"Sensorineural hearing loss in patients with mixed connective tissue disease: Immunological markers and cytokine levels","volume":"36","author":"Hajas","year":"2009","journal-title":"J Rheumatol."},{"key":"10.1016\/j.medcli.2017.06.066_bib0415","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00005792-198007000-00001","article-title":"Mixed connective tissue disease: A subsequent evaluation of the original 25 patients","volume":"59","author":"Nimelstein","year":"1980","journal-title":"Medicine (Baltimore)."},{"key":"10.1016\/j.medcli.2017.06.066_bib0420","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/00002281-200009000-00006","article-title":"Mixed connective tissue disease","volume":"12","author":"Hoffman","year":"2000","journal-title":"Curr Opin Rheumatol."},{"key":"10.1016\/j.medcli.2017.06.066_bib0425","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1191\/0961203302lu220oa","article-title":"MCTD: A concept which stood the test of time","volume":"11","author":"Sharp","year":"2002","journal-title":"Lupus."},{"key":"10.1016\/j.medcli.2017.06.066_bib0430","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/08916930400022715","article-title":"Anti-Sm and anti-RNP antibodies","volume":"38","author":"Migliorini","year":"2005","journal-title":"Autoimmunity."},{"key":"10.1016\/j.medcli.2017.06.066_bib0435","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.rdc.2005.04.004","article-title":"Autoantibodies in the pathogenesis of mixed connective tissue disease","volume":"31","author":"Greidinger","year":"2005","journal-title":"Rheum Dis Clin North Am."},{"key":"10.1016\/j.medcli.2017.06.066_bib0440","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1080\/08916930701262986","article-title":"Anti-ribonucleoprotein antibodies mediate enhanced lung injury following mesenteric ischemia\/reperfusion in Rag-1(\u2212\/\u2212) mice","volume":"40","author":"Keith","year":"2007","journal-title":"Autoimmunity."},{"key":"10.1016\/j.medcli.2017.06.066_bib0445","first-page":"409","article-title":"Anti-endothelial cell antibodies in mixed connective tissue disease: Frequency and association with clinical symptoms","volume":"22","author":"Bodolay","year":"2004","journal-title":"Clin Exp Rheumatol."},{"key":"10.1016\/j.medcli.2017.06.066_bib0450","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/rheumatology\/kev300","article-title":"Associations between anti-Ro52 antibodies and lung fibrosis in mixed connective tissue disease","volume":"55","author":"Gunnarsson","year":"2016","journal-title":"Rheumatology (Oxford)."},{"key":"10.1016\/j.medcli.2017.06.066_bib0455","series-title":"Classification and diagnostic criteria for mixed connective tissue disease","first-page":"33","author":"Alarcon-Segovia","year":"1987"},{"key":"10.1016\/j.medcli.2017.06.066_bib0460","series-title":"Mixed connective tissue diseases and anti-nuclear antibodies","first-page":"23","article-title":"Diagnostic criteria for classification of MCTD","author":"Sharp","year":"1987"},{"key":"10.1016\/j.medcli.2017.06.066_bib0465","series-title":"Mixed connective tissue disease and anti-nuclear antibodies","first-page":"41","article-title":"Prelimary diagnostic criteria for classification of mixed connective tissue disease","author":"Kasukawa","year":"1987"},{"key":"10.1016\/j.medcli.2017.06.066_bib0470","series-title":"Les maladies systemiques","first-page":"545","author":"Kahn","year":"1991"},{"key":"10.1016\/j.medcli.2017.06.066_bib0475","first-page":"328","article-title":"Comparison between 3 diagnostic criteria for mixed connective tissue disease. Study of 593 patients","volume":"16","author":"Alarc\u00f3n-Segovia","year":"1989","journal-title":"J Rheumatol."},{"key":"10.1016\/j.medcli.2017.06.066_bib0480","first-page":"2055","article-title":"Comparative study of 4 diagnosis criteria sets for mixed connective tissue disease in patients with anti-RNP antibodies. Autoimmunity Group of the Hospitals of Toulouse","volume":"23","author":"Amigues","year":"1996","journal-title":"J Rheumatol."},{"key":"10.1016\/j.medcli.2017.06.066_bib0485","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.semarthrit.2011.07.010","article-title":"To be or not to be, ten years after: Evidence for mixed connective tissue disease as a distinct entity","volume":"41","author":"Cappelli","year":"2012","journal-title":"Semin Arthritis Rheum."},{"issue":"5 Suppl 61","key":"10.1016\/j.medcli.2017.06.066_bib0490","article-title":"Use of methotrexate in patients with scleroderma and mixed connective tissue disease","volume":"28","author":"Kowal-Bielecka","year":"2010","journal-title":"Clin Exp Rheumatol."},{"key":"10.1016\/j.medcli.2017.06.066_bib0495","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.3899\/jrheum.101262","article-title":"Expert agreement on EULAR\/EUSTAR recommendations for the management of systemic sclerosis","volume":"38","author":"Walker","year":"2011","journal-title":"J Rheumatol."},{"key":"10.1016\/j.medcli.2017.06.066_bib0500","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1136\/ard.2010.130658","article-title":"Bosentan treatment of digital ulcers related to systemic sclerosis: Results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial","volume":"70","author":"Matucci-Cerinic","year":"2011","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.medcli.2017.06.066_bib0505","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S2213-2600(16)30152-7","article-title":"Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): A randomised controlled, double-blind, parallel group trial","volume":"4","author":"Tashkin","year":"2016","journal-title":"Lancet Respir Med."},{"key":"10.1016\/j.medcli.2017.06.066_bib0510","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1177\/0961203309345782","article-title":"Proposed disease activity criteria for mixed connective tissue disease","volume":"19","author":"Lage","year":"2010","journal-title":"Lupus."},{"key":"10.1016\/j.medcli.2017.06.066_bib0515","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1378\/chest.10-0260","article-title":"Characterization of connective tissue disease-associated pulmonary arterial hypertension from REVEAL: Identifying systemic sclerosis as a unique phenotype","volume":"138","author":"Chung","year":"2010","journal-title":"Chest."},{"key":"10.1016\/j.medcli.2017.06.066_bib0520","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1191\/0961203305lu2205oa","article-title":"Cardiac involvement in autoimmune myositis and mixed connective tissue disease","volume":"14","author":"Lundberg","year":"2005","journal-title":"Lupus."},{"key":"10.1016\/j.medcli.2017.06.066_bib0525","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10067-009-1276-y","article-title":"Fifteen-year experience of pediatric-onset mixed connective tissue disease","volume":"29","author":"Tsai","year":"2010","journal-title":"Clin Rheumatol."},{"key":"10.1016\/j.medcli.2017.06.066_bib0530","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1136\/annrheumdis-2016-209522","article-title":"Long-term outcome in juvenile-onset mixed connective tissue disease: A nationwide Norwegian study","volume":"76","author":"Hetlevik","year":"2017","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.medcli.2017.06.066_bib0535","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s11926-016-0576-x","article-title":"Pediatric mixed connective tissue disease","volume":"18","author":"Berard","year":"2016","journal-title":"Curr Rheumatol Rep."},{"key":"10.1016\/j.medcli.2017.06.066_bib0540","doi-asserted-by":"crossref","first-page":"e000271","DOI":"10.1136\/rmdopen-2016-000271","article-title":"Tocilizumab in the treatment of mixed connective tissue disease and overlap syndrome in children","volume":"2","author":"Cabrera","year":"2016","journal-title":"RMD Open."},{"key":"10.1016\/j.medcli.2017.06.066_bib0545","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s10067-010-1630-0","article-title":"B cell depletion for autoimmune diseases in paediatric patients","volume":"30","author":"Jansson","year":"2011","journal-title":"Clin Rheumatol."},{"key":"10.1016\/j.medcli.2017.06.066_bib0550","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.rdc.2005.04.007","article-title":"Does mixed connective tissue disease exist? Yes","volume":"31","author":"Aringer","year":"2005","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.medcli.2017.06.066_bib0555","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/1529-0131(199805)41:5<768::AID-ART3>3.0.CO;2-Z","article-title":"Mixed connective tissue disease: To be or not to be?","volume":"41","author":"Smolen","year":"1998","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.medcli.2017.06.066_bib0560","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.rdc.2005.04.009","article-title":"Mixed connective tissue disease: Still crazy after all these years","volume":"31","author":"Swanton","year":"2005","journal-title":"Rheum Dis Clin North Am."},{"key":"10.1016\/j.medcli.2017.06.066_bib0565","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3899\/jrheum.140047","article-title":"Performance of the 2013 American College of Rheumatology\/European League Against Rheumatism Classification Criteria for Systemic Sclerosis (SSc) in large, well-defined cohorts of SSc and mixed connective tissue disease","volume":"42","author":"Hoffmann-Vold","year":"2015","journal-title":"J Rheumatol."},{"key":"10.1016\/j.medcli.2017.06.066_bib0570","first-page":"682","article-title":"Evoluci\u00f3n cl\u00ednica y serol\u00f3gica en pacientes con enfermedad mixta del tejido conjuntivo","author":"L\u00f3pez-Longo","year":"1994","journal-title":"Rev Clin Esp."},{"key":"10.1016\/j.medcli.2017.06.066_bib0575","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1136\/annrheumdis-2011-200614","article-title":"Clinical manifestations of antiphospholipid syndrome (APS) with and without antiphospholipid antibodies (the so-called \u2018seronegative APS\u2019)","volume":"71","author":"Rodriguez-Garcia","year":"2012","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.medcli.2017.06.066_bib0580","first-page":"1267","article-title":"Longitudinal fluctuation of antibodies to extractable nuclear antigens in systemic lupus erythematosus","volume":"32","author":"Faria","year":"2005","journal-title":"J Rheumatol."},{"key":"10.1016\/j.medcli.2017.06.066_bib0585","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1046\/j.1365-2249.1999.00961.x","article-title":"Distribution and antigen specificity of anti-U1RNP antibodies in patients with systemic sclerosis","volume":"117","author":"Ihn","year":"1999","journal-title":"Clin Exp Immunol."},{"key":"10.1016\/j.medcli.2017.06.066_bib0590","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1136\/ard.60.2.116","article-title":"Autoantibody profiles in the sera of European patients with myositis","volume":"60","author":"Brouwer","year":"2001","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.medcli.2017.06.066_bib0595","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/1529-0131(199905)42:5<899::AID-ANR8>3.0.CO;2-L","article-title":"Long-term outcome in mixed connective tissue disease: Longitudinal clinical and serologic findings","volume":"42","author":"Burdt","year":"1999","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.medcli.2017.06.066_bib0600","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1002\/art.1780351013","article-title":"Changes in anti-U1 RNA antibody levels correlate with disease activity in patients with systemic lupus erythematosus overlap syndrome","volume":"35","author":"Hoet","year":"1992","journal-title":"Arthritis Rheum."}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775317305882?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775317305882?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,7,3]],"date-time":"2018-07-03T18:24:01Z","timestamp":1530642241000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775317305882"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S0025775317305882"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2017.06.066","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hechos y controversias en la enfermedad mixta del tejido conectivo","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2017.06.066","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}